SG
PEARW

StoneX Group’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

StoneX Group’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$1.7K – 655
2022
Q3 		$1.7K Buy
+10,000
New +$1.47K ﹤0.01% 344

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

StoneX Group's PEARW Position: Q4 2022 in Review

StoneX Group sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q4 2022, closing a stake of 10,000 shares — an estimated $1.7K sold.

StoneX Group first reported a position in PEARW in Q3 2022 and held it in 1 quarter. The position peaked at $1.7K in Q3 2022. 33 funds tracked by Wall St. Rank hold PEARW as of Q4 2022.

  • StoneX Group reported no remaining Pear Therapeutics, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
  • StoneX Group sold 10,000 Pear Therapeutics, Inc. Warrant shares in Q4 2022, an estimated $1.7K.
  • StoneX Group first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2022 and held it in 1 quarter.
  • StoneX Group's Pear Therapeutics, Inc. Warrant position peaked at $1.7K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q4 2022.

Based on StoneX Group's 13F filing for Q4 2022, filed 10 Feb 2023.